| Alexion Pharmaceuticals, Inc. | 113,24 / +0,62% |
| 日期/時間 | 17.01. / 17:22 |
| 漲跌。 / 漲跌。(%) | 0,70 / +0,62% |
| Bid | - |
| Ask | - |
| 打開 | 113,14 |
| 過往收市 | 112,54 |
| 高 | 113,34 |
| 低 | 112,51 |
| 成交量 [USD] | 2.316.636,30 |
| 成交量 [Units] | 20.512 |
| Price fixings | 207 |
| ISIN | US0153511094 |
| 符號 | ALXN |
| 交易所 | IEX |
| 類型 | 股票 |
所有交易
| 交易所 | 最後的 | 成交量 | |
|---|---|---|---|
| NASDAQ | 113,0300 |  |
362.495 |
| Cboe US | 113,00 | |
26.942 |
| IEX | 113,24 | |
20.512 |
| TradeGate | 101,660 |  |
343 |
| London Inter.. | 113,01 | |
180 |
| München | 101,22 | |
1 |
| Düsseldorf | 100,64 | |
0 |
| Frankfurt | 101,4200 | |
0 |
| Berlin | 100,74 | |
0 |
| Vienna Globa.. | 101,18 | |
0 |
| gettex | 101,540 | |
|
| Lang & Schwa.. | 101,76 | |
|
| Stuttgart | 101,520 | |
|
| Mexico | 2.155,00 | |
2.046 |
| Xetra | 101,02 | 0 |
新聞
- Fortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes Disease
16.01.2020 / 14:30 - GlobeNewswire - Fortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children’s Hospital Medical Center to Develop a Novel Treatment for Select CNS Disorders
23.12.2019 / 14:30 - GlobeNewswire - Achillion Shareholders Approve Agreement to be Acquired by Alexion
19.12.2019 / 15:24 - GlobeNewswire - IDG Honors Premier Organizations and Rising IT Leaders Driving Digital Innovation
16.12.2019 / 15:59 - GlobeNewswire - Merus Announces Chief Executive Officer Transition
16.12.2019 / 14:30 - GlobeNewswire
Personal area
Click on 
to activate push quotes.
to activate push quotes.